These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10513456)

  • 1. A strategy to evaluate a covariate by group interaction in an analysis of covariance.
    Leon AC; Portera L; Lowell K; Rheinheimer D
    Psychopharmacol Bull; 1998; 34(4):805-9. PubMed ID: 10513456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes.
    Sullivan LM; D'Agostino RB
    Stat Med; 1996 Mar; 15(5):477-96. PubMed ID: 8668873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical issues on the analysis of change in follow-up studies in dental research.
    Blance A; Tu YK; Baelum V; Gilthorpe MS
    Community Dent Oral Epidemiol; 2007 Dec; 35(6):412-20. PubMed ID: 18039282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.
    Knoke JD
    Biometrics; 1991 Jun; 47(2):523-33. PubMed ID: 1912259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
    Mavissakalian MR; Zamar N
    Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of repeated-measures analysis of variance and hierarchical linear model in nursing research.
    Shin JH
    Nurs Res; 2009; 58(3):211-7. PubMed ID: 19448525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized covariance-adjusted canonical correlation analysis with application to psychiatry.
    Kowalski J; Tu XM; Jia G; Perlis M; Frank E; Crits-Christoph P; Kupfer DJ
    Stat Med; 2003 Feb; 22(4):595-610. PubMed ID: 12590416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytic methods for questions pertaining to a randomized pretest, posttest, follow-up design.
    Rausch JR; Maxwell SE; Kelley K
    J Clin Child Adolesc Psychol; 2003 Sep; 32(3):467-86. PubMed ID: 12881035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of covariance (ANCOVA) with difference scores.
    Jamieson J
    Int J Psychophysiol; 2004 May; 52(3):277-83. PubMed ID: 15094250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pharmacotherapist characteristics on treatment outcome in panic disorder.
    Gorman JM; Martinez JM; Goetz R; Huppert JD; Ray S; Barlow DH; Shear MK; Woods SW
    Depress Anxiety; 2003; 17(2):88-93. PubMed ID: 12621597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 20. A model selection approach to analysis of variance and covariance.
    Alber SA; Weiss RE
    Stat Med; 2009 Jun; 28(13):1821-40. PubMed ID: 19387975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.